Anti-Synthetase Syndrome Presenting as Rapidly Progressive Interstitial Lung Disease by Brewster, Nathan, DO et al.
Lehigh Valley Health Network 
LVHN Scholarly Works 
Department of Medicine 
Anti-Synthetase Syndrome Presenting as Rapidly Progressive 
Interstitial Lung Disease 
Nathan Brewster DO 
Lehigh Valley Health Network, Nathan.Brewster@lvhn.org 
Amogh M. Joshi DO 
Lehigh Valley Health Network, Amogh.Joshi@lvhn.org 
Alaynna C. Kears DO 
Lehigh Valley Health Network, Alaynna.Kears2@lvhn.org 
Kareem Godil MD 
Lehigh Valley Health Network, Kareem.Godil@lvhn.org 
Jessica Boehmler MD 
Lehigh Valley Health Network, Jessica.Boehmler@lvhn.org 
See next page for additional authors 
Follow this and additional works at: https://scholarlyworks.lvhn.org/medicine 
 Part of the Critical Care Commons, Internal Medicine Commons, and the Pulmonology Commons 
Published In/Presented At 
Brewster, N. Joshi, A. Kears, A. Godil, K. Boehmler, J. Zirlinger, A. (2019, October 18). Anti-Synthetase 
Syndrome Presenting as Rapidly Progressive Interstitial Lung Disease. Poster Presented at: CHEST 
Annual Meeting, New Orleans, LA. 
This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion 
in LVHN Scholarly Works by an authorized administrator. For more information, please contact 
LibraryServices@lvhn.org. 
Authors 
Nathan Brewster DO, Amogh M. Joshi DO, Alaynna C. Kears DO, Kareem Godil MD, Jessica Boehmler MD, 
and Andres Zirlinger MD 
This poster is available at LVHN Scholarly Works: https://scholarlyworks.lvhn.org/medicine/1740 
© 2019 Lehigh Valley Health Network
LVHN.org
Anti-Synthetase Syndrome Presenting as  
Rapidly Progressive Interstitial Lung Disease
Nathan Brewster, DO,1 Amogh Joshi, DO,1 Alaynna Kears, DO,1 Kareem Godil, MD,1 Jessica Boehmler, MD,2 Andres Zirlinger, MD2
1Department of Internal Medicine, 2Division of Pulmonary and Critical Care Medicine, Lehigh Valley Health Network, Allentown, Pa.
Introduction
Anti-Synthetase Syndrome is a rare disease seen most commonly in patients 
with auto-immune inflammatory myopathies such as dermatomyositis. 
Typical characteristics of this exceedingly rare syndrome are arthropathy, 
interstitial lung disease (ILD), the presence of antibodies against amino-acyl 
tRNA synthetases, and rarely the typical myositis associated with these 
antibodies. We describe the unfortunate case of a patient with rapidly 
progressive ILD and acute hypoxic respiratory failure necessitating bilateral 
lung transplantation. 
Case presentation
A 47-year-old female with past medical history significant for hypothyroidism 
and hyperlipidemia presented to the office with one month of progressively 
worsening dyspnea and productive cough; her initial chest radiography 
showed bilateral, multi-focal infiltrates. A bronchoalveolar lavage and 
transbronchial and endobronchial biopsies were performed via bronchoscopy 
without significant findings. Extensive infectious work-up was negative. Only 
a few days later, she was admitted to the hospital with severe hypoxemia. 
Computed tomography of the chest without contrast demonstrated worsening 
bilateral airspace disease and rapidly progressing traction bronchiectasis 
(Images 1 and 2). Video-assisted thorascopic surgery (VATS) was performed 
and wedge biopsy demonstrated alveolar tissue containing fibrin with 
surrounding cellular fibrosis. Extensive immunological work-up returned 
positive for the anti-histidyl-tRNA synthetase antibody, Anti-Jo-1, highly 
suggestive of a diagnosis of Anti-Synthetase Syndrome. She was initiated 
on pulse dose steroids and transferred to a transplant center where she 
received bilateral lung transplantation. 
Discussion
•  Anti-Synthetase Syndrome is a rare auto-immune disease that has 
significant systemic manifestations. 
•  Commonly accepted diagnostic criteria for Anti-Synthetase Syndrome 
include the presence of an anti-aminoacyl tRNA synthetase antibody and 
evidence of ILD, Raynaud’s phenomenon, arthritis, or mechanic’s hands. 
•  While this disease falls within the clinical realm of the inflammatory 
myopathies, clinicians must be aware that this syndrome can and often 
does present primarily with rapidly progressing ILD, being the primary 
mediator of morbidity and mortality in these patients. 
•  Clinical suspicion for autoimmune disease should be high, particularly in 
patients with rapidly deteriorating respiratory function without evidence of 
active infection. 
Conclusion
•  This case demonstrates the importance of expeditious and accurate 
identification of autoimmune etiologies in patients presenting with 
respiratory decline. 
•  It is critical to eliminate treatable infectious etiologies to allow for initiation 
of immunosuppressive therapy. 
•  A low threshold for evaluation for transplant should also occur with rapidly 
progressing ILD associated with autoimmune features or serologies.
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Imaging
Image 1. Diffuse airspace disease with traction 
bronchiectasis.
Image 2. Coronal view of patient’s extensive 
lung disease.
